{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:34:08Z","timestamp":1792773248414,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.jcrc.2026.155731","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:37:41Z","timestamp":1788043061000},"page":"155731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Outcomes of patients with Waldenstr\u00f6m macroglobulinemia in ICU: a retrospective multicentric study"],"prefix":"10.1016","volume":"97","author":[{"given":"Camille","family":"Barraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aalliayah","family":"Velletrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Harel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"P\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Biard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2026.155731_bb0005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0954-6820.1944.tb03955.x","article-title":"Incipient myelomatosis or \u201cessential\u201d hyperglobulinemia with fibrinogenopenia \u2014 a new syndrome?","volume":"117","author":"Waldenstrom","year":"1944","journal-title":"Acta Med Scand"},{"issue":"7","key":"10.1016\/j.jcrc.2026.155731_bb0010","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1016\/S2352-3026(18)30087-5","article-title":"Treatment and outcome patterns in European patients with Waldenstr\u00f6m\u2019s macroglobulinaemia: a large, observational, retrospective chart review","volume":"5","author":"Buske","year":"2018","journal-title":"Lancet Haematol"},{"issue":"19","key":"10.1016\/j.jcrc.2026.155731_bb0015","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1182\/blood-2011-10-384768","article-title":"Progression in smoldering Waldenstr\u00f6m macroglobulinemia: long-term results","volume":"119","author":"Kyle","year":"2012","journal-title":"Blood"},{"issue":"9873","key":"10.1016\/j.jcrc.2026.155731_bb0020","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jcrc.2026.155731_bb0025","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2006.07.8659","article-title":"Bortezomib is active in patients with untreated or relapsed Waldenstrom\u2019s macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.jcrc.2026.155731_bb0030","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1200\/JCO.2008.20.4677","article-title":"Primary therapy of Waldenstr\u00f6m macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180","volume":"27","author":"Treon","year":"2009","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.jcrc.2026.155731_bb0035","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa1802917","article-title":"Phase 3 trial of ibrutinib plus rituximab in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"378","author":"Dimopoulos","year":"2018","journal-title":"N Engl J Med"},{"issue":"1D","key":"10.1016\/j.jcrc.2026.155731_bb0040","first-page":"e240001","article-title":"Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphoma, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Kumar","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155731_bb0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/bjh.18680","article-title":"The Rory Morrison WMUK registry for Waldenstr\u00f6m macroglobulinaemia: the growth of a national registry for a rare disorder","volume":"201","author":"Uppal","year":"2023","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155731_bb0050","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the second international workshop on Waldenstrom\u2019s macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155731_bb0055","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155731_bb0060","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on \u2018sepsis-related problems\u2019 of the European Society of Intensive Care Medicine","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155731_bb0065","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155731_bb0070","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archopht.124.11.1601","article-title":"Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia","volume":"124","author":"Menke","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155731_bb0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s44313-025-00079-1","article-title":"Diagnosis and management of neutropenia","volume":"60","author":"Min","year":"2025","journal-title":"Blood Res"},{"key":"10.1016\/j.jcrc.2026.155731_bb0080","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis [Internet]","author":"Harrell","year":"2015"},{"issue":"10","key":"10.1016\/j.jcrc.2026.155731_bb0090","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00134-021-06502-2","article-title":"Critical illness in patients with hematologic malignancy: a population-based cohort study","volume":"47","author":"Ferreyro","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155731_bb0095","doi-asserted-by":"crossref","first-page":"21145","DOI":"10.1038\/s41598-020-78114-7","article-title":"Predictors of intensive care unit admission in patients with hematologic malignancy","volume":"10","author":"Vijenthira","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jcrc.2026.155731_bb0100","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/bjh.16492","article-title":"Cause-specific mortality in individuals with lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia, 2000\u20132016","volume":"189","author":"Dalal","year":"2020","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155731_bb0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00134-024-07349-z","article-title":"Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study","volume":"50","author":"Munshi","year":"2024","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2026.155731_bb0110","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00134-024-07454-z","article-title":"Management of hematological patients requiring emergency chemotherapy in the intensive care unit","volume":"50","author":"Lafarge","year":"2024","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.jcrc.2026.155731_bb0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00277-018-3553-9","article-title":"Prognosis of autoimmune hemolytic anemia in critically ill patients","volume":"98","author":"Lafarge","year":"2019","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.jcrc.2026.155731_bb0120","doi-asserted-by":"crossref","first-page":"E371","DOI":"10.1002\/ajh.26665","article-title":"Characteristics and outcome of adults with severe autoimmune hemolytic anemia admitted to the intensive care unit: results from a large French observational study","volume":"97","author":"Pouchelon","year":"2022","journal-title":"Am J Hematol"},{"issue":"22","key":"10.1016\/j.jcrc.2026.155731_bb0125","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium\u2014a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study","volume":"31","author":"Azoulay","year":"2013","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.jcrc.2026.155731_bb0130","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood.2019000725","article-title":"How I treat Waldenstr\u00f6m macroglobulinemia","volume":"134","author":"Dimopoulos","year":"2019","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jcrc.2026.155731_bb0135","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155731_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.critrevonc.2010.09.007","article-title":"Waldenstr\u00f6m\u2019s macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center","volume":"80","author":"Merchionne","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155731_bb0145","article-title":"Waldenstr\u00f6m macroglobulinemia - a state-of-the-art review: part 1: epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, risk stratification, and clinical problems","volume":"16","author":"Bibas","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155731_bb0150","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1038\/s41375-024-02393-6","article-title":"The clinical impact of acquired von Willebrand syndrome secondary to Waldenstr\u00f6m macroglobulinemia: an underrecognized source of major bleeding events","volume":"38","author":"Chohan","year":"2024","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.jcrc.2026.155731_bb0155","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ajh.24477","article-title":"Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstr\u00f6m macroglobulinemia","volume":"91","author":"Castillo","year":"2016","journal-title":"Am J Hematol"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126003096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126003096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:39:28Z","timestamp":1792766368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944126003096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":30,"alternative-id":["S0883944126003096"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155731","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of patients with Waldenstr\u00f6m macroglobulinemia in ICU: a retrospective multicentric study","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155731"}}